Home-Based Cardiac Rehabilitation for Heart Failure (MOBILE HEART Trial)

N/A

Recruiting

Led By Brian R Lindman, MD, MSCI

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the comparison will be made at 12 weeks.

Awards & highlights

No Placebo-Only Group

Summary

"This trial is testing a new home-based cardiac rehabilitation program for people with heart failure, using a custom app and digital tools. Participants will be split into two groups: one group will receive the home-based

Who is the study for?

This trial is for individuals with heart failure who are unable to participate in center-based cardiac rehabilitation. Participants must have access to a smartphone or tablet and be willing to use an app and digital tools as part of the intervention.

What is being tested?

The study is testing a home-based cardiac rehabilitation (HBCR) program delivered through an app against usual care without this program. It aims to improve physical activity, quality of life, and reduce clinical events by focusing on key health behaviors.

What are the potential side effects?

Since HBCR involves exercise and lifestyle changes rather than medication, side effects may include muscle soreness or injury from new physical activities. The digital nature could lead to privacy concerns if data handling isn't secure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the comparison will be at 12-weeks after randomization.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the comparison will be at 12-weeks after randomization.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the comparison will be at 12-weeks after randomization. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Average daily total activity counts

Secondary study objectives

"Thriving patient" composite

5 meter gait speed

6 minute walk distance

+23 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Home-based cardiac rehabilitation mobile health interventionExperimental Treatment1 Intervention

Home-based cardiac rehabilitation with mobile application and periodic video calls with exercise physiologist + AHA Life's Essential 8 sheets.

Group II: ControlActive Control1 Intervention

Standard of care course for an individual not participating in center based cardiac rehabilitation. AHA Life's Essential 8 Fact Sheets are provided to promote healthy living.

Do I qualify?Apply below to find out